Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01676389 · ClinicalTrials.gov registry record · NA
Osteopathic Manual Medicine Treatment in Autism
A NA study, sponsored by New York Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01676389 is a NA study that has completed, run by New York Institute of Technology. The registered enrollment target is 3 participants.
The verdict
NCT01676389, a NA study, has completed, sponsored by New York Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how osteopathic manual medicine (OMM) will affect core autism features including social and communication deficits. The investigators believe that OMM approaches can positively influence some features associated with Autism/Autism Spectrum Disorder (ASD).
Interventions
- OTHER Sham OMM
- OTHER Osteopathic Manual Medicine (Body Therapy)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01676389
The ClinicalTrials.gov registry entry for NCT01676389 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York Institute of Technology, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham OMM is the first listed.
NCT01676389 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01676389 about?
NCT01676389 is a clinical study titled "Osteopathic Manual Medicine Treatment in Autism". The purpose of this study is to determine how osteopathic manual medicine (OMM) will affect core autism features including social and communication deficits. The investigators believe that OMM approaches can positively influence some features associated with Autism/Autism Spectrum Disorder (ASD).
What is the current status of trial NCT01676389?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2013-01. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01676389?
The interventions under investigation include: Sham OMM (OTHER), Osteopathic Manual Medicine (Body Therapy) (OTHER).
Who is sponsoring clinical trial NCT01676389?
This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.